Log In
Print this Print this

NuThrax (AV7909)

  Manage Alerts
Collapse Summary General Information
Company Emergent BioSolutions Inc.
DescriptionThird generation anthrax vaccine that consists of BioThrax, an adsorbed anthrax vaccine, and CPG 7909, an immunostimulatory compound
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationAnthrax
Indication DetailsPrevent anthrax infection
Regulatory Designation U.S. - Fast Track (Prevent anthrax infection)
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today